Hacker News Reader

Exactly. If you decimate pharma companies' profits, you kill their incentive to innovate. You can't have it both ways.

Let the NIH and DARPA innovate and be done with the sham for-profit pharma is.

The NIH and DARPA are more than welcome to compete with the pharmas and offer lower prices. This is exactly how capitalism works.

$9.4B revenue, $18.9M in CEO salary, $830M in operating income last year. So tired of the threat of killing the incentive to innovate.